POS0255 PREDICTORS OF ANTIBODY RESPONSE TO COVID-19 VACCINE IN RITUXIMAB TREATED PATIENTS WITH INFLAMMATORY RHEUMATIC DISEASES. A SWEDISH NATIONWIDE STUDY (COVID19-REUMA)

Frodlund M, Chatzidionysiou K, Södergren A, Klingberg E, Hansson M, Pin E, Olsson S, Bengtsson A, Klareskog L, Kapetanovic MC

Ann Rheum Dis 81 (-) 368-369 [2022-06-00; online 2022-06-00]

DOI 10.1136/annrheumdis-2022-eular.2788

Crossref 10.1136/annrheumdis-2022-eular.2788